Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis including current skin involvement: results of a phase 3, randomized, controlled trial
Services
Services
Date issued
2013Journal title
Annals of the rheumatic diseases
Type of content
Publicación de congreso
